2018 Volume 39 Issue 2 Pages 299-302
A 54-year-old male treated with dabigatran for atrial fibrillation presented to the hospital with hemoptysis, tachypnea and reduced oxygenation. The patient was placed on mechanical ventilation, but the hemoptysis was difficult to control. Therefore, idarucizumab was administered in addition to blood transfusion. Subsequently, the hemoptysis improved, and his coagulation test results normalized. After receiving steroid pulse therapy and plasma exchange, the patient was discharged home on hospital day 50. Results of multiple tests yielded a diagnosis of alveolar hemorrhage caused by microscopic polyangiitis. To manage hemorrhagic complications in patients receiving oral anticoagulants, antidotes specific to each anticoagulant should be developed.
